Rationale and design of NUDGE-FLU-CHRONIC and NUDGE-FLU-2: Two nationwide randomized trials of electronic nudges to increase influenza vaccination among patients with chronic diseases and older adults during the 2023/2024 influenza season
Niklas Dyrby Johansen(Gentofte Hospital), Tor Biering‐Sørensen(Copenhagen University Hospital), Safia Chatur(Brigham and Women's Hospital), Lars Køber(University of Copenhagen), Jens‐Ulrik Stæhr Jensen(University of Copenhagen), Scott D. Solomon(Brigham and Women's Hospital), Ankeet S. Bhatt(Kaiser Permanente San Francisco Medical Center), Muthiah Vaduganathan(Brigham and Women's Hospital), Carsten Schade Larsen(Emory Healthcare), Daniel Modin(University of Copenhagen), Tyra Grove Krause(Statens Serum Institut), Kira Hyldekær Janstrup(University of Copenhagen), Cyril Jean‐Marie Martel(Statens Serum Institut), Michael Dalager‐Pedersen(Aalborg University Hospital), Pradeesh Sivapalan(Gentofte Hospital), Brian Claggett(National Heart Lung and Blood Institute), Lykke Larsen(Odense University Hospital), Lothar Wiese(Zealand University Hospital)
Cited by 10
Related Papers
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
|Journal of the American Society of Echocardiography|2005|11.3k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest
|New England Journal of Medicine|2013|2.8k